Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh Medical Dialogues Bureau21 Aug 2019 10:00 AM ISTThe audit of Dr Reddy's formulations manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam by the United States Food and Drug...
Natco Pharma gets 6 USFDA observations for API facility near Hyderabad Medical Dialogues Bureau13 Aug 2019 1:16 PM ISTNatco Pharma said it will provide due justifications and corrective action plan within the next 15 working days to address the USFDA observations.NEW...
Unichem Labs gets 4 USFDA observations for Goa formulation facility Farhat Nasim3 Aug 2019 9:39 AM ISTAt the end of an inspection, the facility received four observations, with no repeat observations and are mostly procedural in nature, Unichem Labs...
Granules India completes USFDA inspection for Bonthapally facility with one observation Farhat Nasim29 July 2019 10:00 AM ISTGranules India Ltd's Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plant by volume. New Delhi: Drug...
Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report Farhat Nasim26 April 2019 2:20 PM ISTNew Delhi: Sun Pharmaceutical (Sun Pharma) Industries Ltd's Dadra plant has reportedly received 11 observations, "serious" in nature from the U.S....
Torrent Pharma gets USFDA observations for Dahej plant Farhat Nasim9 April 2019 9:30 AM ISTTorrent Pharma announced that the audit at Dahej plant in Gujarat was carried out by US Food and Drug Administration (USFDA) in March 2019. New Delhi:...
Divis Labs gets 6 USFDA observations for Vizag unit Ruby Khatun Khatun21 Sept 2017 10:27 AM ISTNew Delhi: Drug firm Divis Laboratories on Thursday said it has received six new observations from the US Food and Drug Administration (USFDA) after...
